Soluble AXL (sAXL) has recently been utilized as a serum biomarker for liver fibrosis and cirrhosis (Dengler et al., 2017), and has been associated with CKD (Lee et al., 2015). The gene discussed is AXL; the disease is chronic kidney disease.